<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8D6B540D-3EA5-47AE-A05F-180C21CC06CC"><gtr:id>8D6B540D-3EA5-47AE-A05F-180C21CC06CC</gtr:id><gtr:name>Thermo Fisher Scientific</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0B739936-E847-4D0C-8C2A-AE0C504D9F9A"><gtr:id>0B739936-E847-4D0C-8C2A-AE0C504D9F9A</gtr:id><gtr:name>Lausanne University</gtr:name><gtr:address><gtr:line1>Lausanne University</gtr:line1><gtr:line2>Dorigny</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6"><gtr:id>2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6</gtr:id><gtr:name>Faculty of Health Sciences</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8D6B540D-3EA5-47AE-A05F-180C21CC06CC"><gtr:id>8D6B540D-3EA5-47AE-A05F-180C21CC06CC</gtr:id><gtr:name>Thermo Fisher Scientific</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0B739936-E847-4D0C-8C2A-AE0C504D9F9A"><gtr:id>0B739936-E847-4D0C-8C2A-AE0C504D9F9A</gtr:id><gtr:name>Lausanne University</gtr:name><gtr:address><gtr:line1>Lausanne University</gtr:line1><gtr:line2>Dorigny</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6"><gtr:id>2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6</gtr:id><gtr:name>Faculty of Health Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E1F23693-3708-4C16-BA2A-4FB09770E685"><gtr:id>E1F23693-3708-4C16-BA2A-4FB09770E685</gtr:id><gtr:firstName>Syed</gtr:firstName><gtr:otherNames>Hasan</gtr:otherNames><gtr:surname>Arshad</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A191A3B7-22B5-4036-8F3F-ED5D3BD895F4"><gtr:id>A191A3B7-22B5-4036-8F3F-ED5D3BD895F4</gtr:id><gtr:firstName>Adnan</gtr:firstName><gtr:surname>Custovic</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BEE13ECD-52F6-48F9-8F5D-E531DD959FCB"><gtr:id>BEE13ECD-52F6-48F9-8F5D-E531DD959FCB</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Cullinan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9E500403-291B-4FE4-AB79-023730242F30"><gtr:id>9E500403-291B-4FE4-AB79-023730242F30</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Buchan</gtr:surname><gtr:orcidId>0000-0003-3392-1650</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F70BC32F-8A32-4BAB-BA6D-EC0C4E1E18AF"><gtr:id>F70BC32F-8A32-4BAB-BA6D-EC0C4E1E18AF</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Roberts</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C9E10D02-E579-4534-98A7-C9DDBBA115B3"><gtr:id>C9E10D02-E579-4534-98A7-C9DDBBA115B3</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Holloway</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3B7B6483-DCCB-46F4-AFFF-AA453E70C511"><gtr:id>3B7B6483-DCCB-46F4-AFFF-AA453E70C511</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Devereux</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E836385F-2FF1-4116-A5B2-51C175C797AE"><gtr:id>E836385F-2FF1-4116-A5B2-51C175C797AE</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/348A08CE-2AFE-4EE9-A5FA-953ABF3B4E58"><gtr:id>348A08CE-2AFE-4EE9-A5FA-953ABF3B4E58</gtr:id><gtr:firstName>Angela</gtr:firstName><gtr:surname>Simpson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/911A81D0-F61E-4E36-B014-928280D34731"><gtr:id>911A81D0-F61E-4E36-B014-928280D34731</gtr:id><gtr:firstName>Alexander John</gtr:firstName><gtr:surname>Henderson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FK002449%2F1"><gtr:id>BE5B1F2C-F5E4-4253-968D-9C7D9EA3D818</gtr:id><gtr:title>MICA: STELAR (Study Team for Early Life Asthma Research) consortium - Asthma e-lab and identification of novel endotypes of childhood asthma</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K002449/1</gtr:grantReference><gtr:abstractText>Asthma is the most common chronic disease of childhood and causes many hospital admissions. The number of children suffering from asthma has increased dramatically over the past 30 years. It is unclear why some people get asthma and others do not. Asthma is largely heritable, but despite lots of effort we have had limited success identifying which genes are important, and genetic studies of asthma have not yet had a positive impact on patient care. Many factors in the environment may contribute to the development of asthma (for example diet, immunizations, antibiotics, pets and tobacco smoke) but we don't know how to modify the environment to reduce the risks. One reason for the difficulty in understanding causes of asthma is that asthma may be a collection of different diseases which cause similar symptoms. As asthma generally starts early in life, the best way to study it is to recruit new born babies and follow them as they grow (so-called birth cohort). During early life it is possible to measure many things, such as exposure to allergens, (generally cats, dogs and dust mite) constituents of the diet and antibiotic usage. Questionnaires are used to collect information from parents about symptoms, and as the children get older they can take part in measurements of lung function and allergy testing. Most are willing to give sample for genetic testing. In the UK there are 5 such birth cohorts that have been designed to facilitate the study of risk factors for asthma and allergies. The Manchester Study has more than 1,000 children under active follow up; clinical follow up is complete for age 1, 3, 5, 8 and 11 years. The study from Aberdeen included 1,924 children who were followed up 6 months, 1, 2, 5 and 10 years. The Ashford birth cohort followed 642 children until age 12 years. The Isle of Wight study recruited 1,456 children, completing follow up at ages 1, 2, 4, 10 and 18 years. ALSPAC recruited through antenatal clinics in the former County of Avon, and enrolled 14,062 infants. Follow up is complete to age 16 years. All have collected data using questionnaire and performed measures of lung function and skin tests at intervals throughout early life. The researchers who lead these studies have worked together as a network over the last 7 years - the Study Team for Early Life Asthma Research (STELAR consortium). Over recent years we have adopted identical research methodologies, recognising that although each cohort is unique, there are many aspects in which we can work together, to increase our chances of detecting the main causes of asthma. We now propose to create a major new alliance which will combine our world-leading expertise in birth cohorts (STELAR consortium) with expertise in health informatics research (NW Institute for Bio-Health Informatics) and cutting-edge computational statistical methods (so-called statistical machine learning, with experts at our Industrial partner at Microsoft Research Cambridge). Our alliance includes clinicians, public health and epidemiology researchers, statisticians, informaticians and software engineers. We will construct a web based resource (Asthma e-Lab) in which to securely store all the data collected on the cohorts and recipes for analysing the data so that a larger group of scientists can repeat the work. This will enable consistent recording, description and sharing of data and emerging findings across all partners. We will also complete clinical follow-up of cohort participants where necessary. We will work together to apply newly developed state-of-the-art data analysis techniques to build complex models to describe different types of 'asthma' and investigate risk factors for each asthma subtype. In doing so we hope to understand the basic biological mechanisms that underlie the different forms of asthma, Our findings may underpin new trials of asthma prevention and may help identify targets for the discovery of novel therapies which are matched to specific patients.</gtr:abstractText><gtr:technicalSummary>Asthma epidemiology is reaching the limit of what can be achieved through conventional hypothesis-driven research. We hypothesise that asthma is not a single disease, but a condition comprising multiple distinct disease entities (asthma endotypes), each with characteristic pathophysiology and risk factors, and that unbiased novel endotypes of asthma can be identified using complex, rich and expanding datasets from existing UK birth cohort studies by applying a combination of biostatistical and machine learning methods. We propose to form a major Alliance between MRC-funded network of all UK-based birth cohorts designed to study asthma (STELAR consortium), expertise in epidemiologically oriented health informatics research (NW Institute for Bio-Health Informatics) and experts in statistical machine learning (Microsoft Research Cambridge). We will capitalise on the unique collection of well characterised birth cohorts with harmonised clinical outcomes (ALSPAC, SEATON, MAAS, Ashford, Isle of Wight). We will create a secure web-based research environment (Asthma e-Lab) to support consistent recording, description and sharing of data and emerging findings across all partners, thus enabling collaborative epidemiology in near-real-time. The activities of data managers and researchers from the 5 STELAR sites will be made visible to one another, supporting team coordination and peer support and creating a scientific social network to enrich the ongoing modelling and interpretation. We will create and maintain across the consortium annotated dependency graphs of the problem space around the organising principles underlying asthma, and use a machine learning approach interactively over the combined datasets via Asthma e-Lab to discover the unbiased endotypes of asthma. Our findings may underpin new trials of asthma prevention and treatment, personalised for specific endotypes and may help identify novel targets for the discovery of endotypes-specific stratified treatments.</gtr:technicalSummary><gtr:potentialImpactText>The proposal facilitates the evaluation of all data from all subjects enrolled in UK-based birth cohorts on asthma (MRC-funded STELAR consortium). Beneficiary engagement will include active interactions within the trans-disciplinary team, with the general public and patient organisations and the clinical community.
We will establish a multi-disciplinary/multi-institutional collaborative partnership to develop a unified modelling approach that can take full advantage of this unparalleled resource. This will allow us to exploit fully the complexity of data, maximise sharing and linkage of data, and to develop data storage, which is in line with the MRC strategic aim 4. We will develop innovative resources for interdisciplinary collaboration - a step beyond sharing resources. Through Asthma e-Lab, we will create conditions to open up the analysis process and networking around the results to a range of investigators across the project, creating a trans-disciplinary informatics environment which will include epidemiologists, public health researchers, statisticians, informaticians and software engineers. We will draw upon our experience of a similar task in the ESRC-funded Obesity e-Lab project which produced Methodbox to offer fine-grained security and professional social networking facilities to enable investigators to find, extract, share, and reuse data extracts from large complex longitudinal data sets. The e-lab system will allow investigators to collaborate on-line over on-going analyses through the browser-based interface with networking facilities. An on-line STELAR community will be nurtured to maximise the transfer of knowledge between different areas of expertise.
We will extend this approach to a doctoral training scheme. Enabling the networking of datasets, expertise and methods for data preparation and analysis can help drive greater value from existing investments.
Engagement with general public will be undertaken through a combination of electronic communication (websites) and articles in newsletters, together with direct interaction with the public through the media (newspapers, radio, TV), public lectures and involvement with schools (e.g. through regular engagement events at the University of Manchester aimed at students between the ages of 12 and 18 year, who visit the University to learn more about the research we do). We will use these events to engage students about the importance of the work we carry out to understand asthma, and how this can potentially help people in the future.
Dissemination to UK and International clinical communities will be led by co-applicants (principal investigators from 5 UK birth cohorts).
Endotypes of asthma will be defined through the fusion of computational thinking and novel mathematical approaches with biomedical and environmental science and genetics. These novel endotypes better reflect the different underlying pathophysiological processes and molecular pathways underpinning different diseases in the asthma syndrome, and may be more relevant for epidemiological, genetic and therapeutic studies. The outputs will enable the UK to maintain world leadership by gaining insight into genetic and environmental interactions underlying asthma and better understanding of how different physiological processes work together (in line with the MRC strategic aim 1). This strategy may lead to the development of methods for prevention that are endotype-specific, and through better understanding of the disease mechanisms, identification of endotype-specific novel therapeutic targets. The findings may represent potentially valuable intellectual property, which we will seek to commercialise in collaboration with companies with interests in diagnostics and/or therapeutics. Participating universities have mechanisms and structures in place for exploring industrial applications both during and at the end of the lifecycle of the project grant.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-09-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-01-25</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1498108</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wisconsin-Madison</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The CREW consortium</gtr:description><gtr:id>60697E0A-C198-4929-8414-373A1DD83EEE</gtr:id><gtr:impact>We have created conditions that will facilitate data sharing with the consortium of 12 US-based birth cohorts.</gtr:impact><gtr:partnerContribution>The National Institutes of Health (NIH) has awarded the University of Wisconsin School of Medicine and Public Health a two-year, $15 million grant to establish and oversee the Children's Respiratory Research and Environment Workgroup (CREW) - a national consortium of 14 institutions that will study how genetics interact with environmental exposures during the prenatal and early childhood years to cause specific subtypes of childhood asthma.</gtr:partnerContribution><gtr:piContribution>We have created conditions that will facilitate data sharing with the consortium of 12 US-based birth cohorts (CREW). NIH has just announced that CREW were awarded funding through the Environmental influences on Child Health Outcomes (ECHO) programme, and CREW will utilise our UK STELAR knowledge management platform (eLab). This will provide a worldwide platform to help solve the global problem of asthma. Our flexible platform will be able to accommodate other cohorts and disease outcomes in future</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>7B006ABC-76E2-40E5-95DD-3886459A7043</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Imperial College of Science Technology and Medicine (ICSTM)</gtr:department><gtr:description>MRC/BBSRC Flagship Consortium in Systems Immunology of the Human Life Course</gtr:description><gtr:id>F658D778-1961-42A7-ABCC-CA701AE05C31</gtr:id><gtr:impact>Grant award:
MRC Grant MR/L012693/1: Co-applicant 
MRC/BBSRC Flagship Consortium in Systems Immunology of the Human Life Course: Phenotyping immune responses in asthma and respiratory infections - a systems approach to understanding changes from childhood to adulthood. 01/01/2014-31/12/2018, &amp;pound;2,200,000</gtr:impact><gtr:partnerContribution>The proposal cements a major Collaboration between the MRC &amp;amp; Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London and the MRC/GSK Alliance, which is a major new initiative stemming from the Centre investigating interplay between infections and asthma exacerbations, with STELAR consortium and the MRC HeRC.</gtr:partnerContribution><gtr:piContribution>We will harness the power of computational and systems biology to the rich clinical (on asthma, allergies and RTIs), immunological, genetic, epigenetic and environmental data sets, in hundreds of subjects, either already available in the Manchester Allergy and Asthma Study (MAAS) birth cohort, or which will be supplemented with new datasets that we plan to collect as part of this proposal to generate:
? complete clinical follow up and sampling of the cohort to from birth to adulthood at 18yrs of age
? complex functional characterisation of immune responses to viral and bacterial infections in blood cells collected in childhood (8yrs), early (11yrs) and late (14yrs) puberty and adulthood (18yrs)
? next generation sequencing of targeted relevant immune genes
? component resolved allergy diagnostics at 8, 11, 14 and 18yrs
? gene methylation studies in blood cells collected at 8, 11, 14 and 18yrs
We will establish a multi-disciplinary/multi-institutional collaborative partnership that can take full advantage of this resource, enabling us to fully exploit the data complexity and to maximise the linkage, preservation and sharing of data.
UK birth cohorts are amongst the strongest worldwide; amongst them, the MAAS collected the most detailed information which is essential for the delivery of this ambitious programme; such a unique high-quality resource cannot easily be replicated.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University of Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>A076D40E-06F8-48EE-94CC-AF1F86224B7D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lausanne</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>09699139-B723-4B0F-92F4-87E60B256520</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>9FB76D45-44AF-448C-8101-2489C1980966</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Thermo Fisher Scientific</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MRC/BBSRC Flagship Consortium in Systems Immunology of the Human Life Course</gtr:description><gtr:id>989DDB0D-D050-4A9A-8E7C-A28DB794D9CD</gtr:id><gtr:impact>Grant award:
MRC Grant MR/L012693/1: Co-applicant 
MRC/BBSRC Flagship Consortium in Systems Immunology of the Human Life Course: Phenotyping immune responses in asthma and respiratory infections - a systems approach to understanding changes from childhood to adulthood. 01/01/2014-31/12/2018, &amp;pound;2,200,000</gtr:impact><gtr:partnerContribution>The proposal cements a major Collaboration between the MRC &amp;amp; Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London and the MRC/GSK Alliance, which is a major new initiative stemming from the Centre investigating interplay between infections and asthma exacerbations, with STELAR consortium and the MRC HeRC.</gtr:partnerContribution><gtr:piContribution>We will harness the power of computational and systems biology to the rich clinical (on asthma, allergies and RTIs), immunological, genetic, epigenetic and environmental data sets, in hundreds of subjects, either already available in the Manchester Allergy and Asthma Study (MAAS) birth cohort, or which will be supplemented with new datasets that we plan to collect as part of this proposal to generate:
? complete clinical follow up and sampling of the cohort to from birth to adulthood at 18yrs of age
? complex functional characterisation of immune responses to viral and bacterial infections in blood cells collected in childhood (8yrs), early (11yrs) and late (14yrs) puberty and adulthood (18yrs)
? next generation sequencing of targeted relevant immune genes
? component resolved allergy diagnostics at 8, 11, 14 and 18yrs
? gene methylation studies in blood cells collected at 8, 11, 14 and 18yrs
We will establish a multi-disciplinary/multi-institutional collaborative partnership that can take full advantage of this resource, enabling us to fully exploit the data complexity and to maximise the linkage, preservation and sharing of data.
UK birth cohorts are amongst the strongest worldwide; amongst them, the MAAS collected the most detailed information which is essential for the delivery of this ambitious programme; such a unique high-quality resource cannot easily be replicated.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>4256BD3F-7258-4054-869F-754D7914087F</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Health Sciences</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Copenhagen Prospective Studies on Asthma in Childhood (COPSAC)</gtr:department><gtr:description>The EArly Genetics and Lifecourse Epidemiology (EAGLE) Consortium</gtr:description><gtr:id>946E6993-F89E-4171-8FBB-EFEF78C64588</gtr:id><gtr:impact>B&amp;oslash;nnelykke K, Matheson M, Pers TH, Raquel Granell R; Strachan DP, Alves AC, Linneberg A, Curtin JA, Warrington NM, Standl M, Kerkhof M, Jonsdottir I, Kljaic-Bukvic B, Kaakinen M, Sleimann P, Thorleifsson G, Thorsteinsdottir U, Schramm K, Baltic S, Kreiner-M&amp;oslash;ller E, Simpson A, St Pourcain B; Coin L, Hui J, Walters H, Tiesler CMT, Duffy D, Jones G, AAGC, Ring SM, McArdle WL, Price L, Robertson C, Pekkanen J, Tang C, Thiering E, Montgomery G, Hartikainen AL, Dharmage S, Husemoen LL, Herder C, Kemp JP, Elliot P, James A, Waldenberger M, Abramson M, Fairfax BP, Knight JC, Gupta R, Thompson P, Holt P, Sly P, Hirschhorn JN, Blekic M, Weidinger S, Hakonarsson H, Stefansson K, Heinrich J, Postma DS, Custovic A, Pennell CE, Jarvelin MR, Koppelman GH, Timpson N, Ferreira M, Bisgaard H, Henderson AJ. Meta-analysis of genome-wide association studies identifies 10 loci influencing allergic sensitization. Nat Genet. 2013;45(8):902-6. doi: 10.1038/ng.2694.]</gtr:impact><gtr:partnerContribution>Data access for GWAS meta-analyses</gtr:partnerContribution><gtr:piContribution>The EArly Genetics and Lifecourse Epidemiology (EAGLE) Consortium is a consortium of pregnancy and birth cohorts that aims to collaborate to investigate the genetic basis of phenotypes in antenatal and early life and childhood.

EAGLE covers a broad range of pathways and phenotypes, and will integrate closely with the DOHaD (developmental origins of health and disease) community.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>3652A5CB-E0EC-4D22-BB57-11EB856E154B</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>C9203560-D56A-4EC4-B277-DB4D5D195E6B</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Strategic Award WT Strategic Award WT108818MA</gtr:description><gtr:id>307D3D77-14D0-4871-A2FF-4E3D5B648575</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>Genome-wide genotyping data are currently available in only 2 STELAR cohorts, and we will increase the power of the discovery platform by adding genome-wide genotyping data from the others. We will develop cutting-edge analyses to map the latent structure of wheezing illnesses in children, to understand the biological pathways underpinning the phenotypic variation and to test these findings in the experimental workstreams of this programme. In turn we will test the clinical and population-attributable significance of novel biomarkers discovered in workstreams 2-4.</gtr:partnerContribution><gtr:piContribution>Population-based birth cohorts, which eliminate recall bias and enable repeated longitudinal long term phenotyping are the preferred method for understanding patterns of different wheezing subtypes and relating them to different genetic readouts.
A major challenge is how best to utilise vast amounts of data and correlations between them to identify the latent (hidden) causes of phenotypes. By delineating the latent structure underlying the observed disease variation, we anticipate that pathophysiological processes specific to latent factors or classes will be identified. STELAR latent structures will be applied to the infants recruited in WS1 and then we will determine if there are differences between classes in the mechanistic studies of WS2-4. Conversely, the significance of novel molecules and pathways detected in these workstreams can be determined by mapping them to STELAR latent classes. Rather than data-mining, analyses will be informed by biological and clinical hypotheses. It is essential to integrate data; models/methods that can be tailored in full to the problem space; and human expertise to tailor models/methods and make sense of results in context. Bringing the data, methods and investigators together on-line is the key objective of the MRC-funded Study Team for Early Life Asthma Research (STELAR) consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ERS Gold medal for asthma</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>72D22BD5-9AEA-446E-B05C-92322208525C</gtr:id><gtr:impact>ERS has launched this new award to recognise excellence in asthma research. The ERS Maurizio Vignola Gold Medal in Asthma grants ?50,000 to a researcher who has made an outstanding contribution in the field of asthma and is pursuing an active research project in asthma.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.aukcar.ac.uk/professor-custovic-presented-with-ers-maurizio-vignola-gold-medal-in-asthma/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article on STELAR in the International Innovation</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2517E4FD-F27F-4B84-8C30-7D650285BE15</gtr:id><gtr:impact>Report used across as many channels of dissemination as possible to increase awareness of a project (e.g. electronic version of the report on external websites, wide distribution of the digital publication, article PDF emailed to all partners and stakeholders)

STELAR dissemination programme.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.research-europe.com/magazine/HEALTHCARE2/EF23/index.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC North West Tonight News: Manchester Asthma and Allergy Study</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6E77998E-8228-45F4-938F-4A46853FF030</gtr:id><gtr:impact>TV coverage of the celebration of 20 years of MAAS

Study participants felt very proud to be very proud to be part of MAAS.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/uk-england-manchester-28152507</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media interest (antibiotic study)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>17F7650A-4505-426A-9811-591776CDA777</gtr:id><gtr:impact>Multiple TV and newspaper articles

Several interviews with journalists (nwspapers, TV)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.manchestereveningnews.co.uk/news/health/manchester-scietists-discover-childhood-asthma-7126186</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Celebration of 20 years of Manchester Asthma and Allergy Study</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8A193FCD-A019-4D43-BA62-C1C5E448E982</gtr:id><gtr:impact>Increased enthusiasm for continued participation in the study.

After my talk, we received exceptional feedback:

&amp;quot;I wanted to send you a note of thanks for the event yesterday evening, please pass on the thanks and regards of myself and my daughter Catherine to all your team. It was great to see the progress which has been made with the use of the data you have obtained from the group, and the passion and enthusiasm for the project was infectious. It was a great idea to make contact in this was and at this stage of the youngster's lives, and we wanted to wish you good luck with all future research in this area. It's been a privilege for us to play our small part.&amp;quot;

&amp;quot;I just wanted to say a big thank you for last night. What an amazing evening. Myself and Scott really enjoyed hearing about what's been happening and the progress made so far and how exciting the future is.&amp;quot;

&amp;quot;Just wanted to say thanks for an informative evening last night. It's amazing to see what happens after our visits to you. Looking forward to see Xxxxx on the TV today.&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/uk-england-manchester-28152507</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Asthma UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>65E0BB89-87CA-4029-BE86-0332DC87E5B9</gtr:id><gtr:impact>Visit to Asthma UK to publicise the work of the STELAR consortium</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Allergy web chat</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C09C7A58-19E4-4A16-8992-0109299308E7</gtr:id><gtr:impact>Allergy web chat focussed on:
How do I find out what triggers my seasonal allergies? 
What is the difference between a food allergy and a food intolerance? 
What should I know about anaphylactic shock?
Can allergies be 'cured'?</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CBB23371-B29F-4097-8C33-036280A626B2</gtr:id><gtr:impact>Inaugural lecture of Professor Adnan Custovic. The talk is now available on the Imperial College London website 
Response from the attendees: &amp;quot;Your talk and career story greatly motivated me to join team science research for the next step.&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=WKL7Z99YC0k</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERS Maurizio Vignola Gold Medal in Asthma 2015</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>853EE0DA-F791-45FF-8FE1-686FB333B659</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4640000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award: Pulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma?</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>WT108818MA</gtr:fundingRef><gtr:id>5F723B78-03EE-45C2-96A2-EFA0120D11D2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Skills Fellowship - Career Development Award in Biostatistics to Dr Danielle Belgrave</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BC30B65C-F60E-4679-903F-63CDF0514586</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1999074</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC &amp;amp; Asthma UK Centre in Allergic Mechanisms of Asthma</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:fundingRef>AUK-BC-2015-01</gtr:fundingRef><gtr:id>B2EF9B4C-CE5C-4296-A082-E5470F11854F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Health eResearch Centre (HeRC) doctoral training scheme</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AEEDB4A8-BA7F-40B8-A892-FCAB3BBB159C</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BBSRC Systems Immunology of the Human Life Course</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012693/1</gtr:fundingRef><gtr:id>86C29D41-2C63-475A-BD5A-9283D8331FCA</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We created a secure web-based research environment (Asthma e-Lab; www.asthmaelab.org) to support consistent recording, description and sharing of data, computational statistical methods and emerging findings across the cohorts. The Asthma e-Lab serves as a data repository populated with a unified dataset from our well-defined birth cohorts; in addition, it provides the computational resources and a scientific social network to support timely, collaborative research across the consortium. The activities of data managers and investigators from the five STELAR sites are visible to one another, supporting team coordination and peer support, whilst creating a record of activity to ensure transparency. Researchers inputting the data can see how the data are being used in the analyses, and receive on-line training via the e-Lab, thereby harmonising the relevant knowledge, skills and practices needed to create a consistent STELAR dataset. Emerging findings are shared with all sites via the e-Lab, linked to explanations of analytical methods that might not be familiar to all participants, thereby creating a scientific social network enriching the on-going modelling and interpretation.</gtr:description><gtr:id>0822E5DE-FB77-4887-A205-FBAEC9400ACA</gtr:id><gtr:impact>We have created conditions that will facilitate data sharing with the consortium of 12 US-based birth cohorts (CREW). NIH has just announced that CREW were awarded funding through the Environmental influences on Child Health Outcomes (ECHO) programme, and CREW will utilise our UK STELAR knowledge management platform (eLab). This will provide a worldwide platform to help solve the global problem of asthma. Our flexible platform will be able to accommodate other cohorts and disease outcomes in future.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:protection>Protection not required</gtr:protection><gtr:title>STELAR Asthma eLab</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The NICE Medical Technologies Evaluation Programme</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EA7E919C-ED3F-45AA-8CAE-0859D4847017</gtr:id><gtr:impact>Providing expert advice on new technology. Information from Expert Advisers is fundamental to producing well informed NICE guidance.</gtr:impact><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ARIA guidelines 2016</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C230F802-ECF7-46E0-A359-2A2283D2BB3A</gtr:id><gtr:impact>Improvement in outcomes in allergic rhinitis</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AEF11C19-648B-4F62-AD69-1101FE8133C0</gtr:id><gtr:impact>The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control.</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI position paper: A new framework for the interpretation of IgE sensitization tests</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>DB7DBF2C-4AA7-4FF5-B307-8A7B3FFEA7E8</gtr:id><gtr:impact>A new framework for the interpretation of IgE sensitization tests</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI position paper: Allergy in severe asthma</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>8818DE2C-720D-4BF2-B53A-85ACE2E8BF03</gtr:id><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>My work has shown that the IgE response to the major peanut allergen Ara-h-2 is much more predictive of true peanut allergy (100% sensitivity and 96.1% specificity) than currently used skin or blood tests (PMID:20109746;21272928). This component-resolved diagnostics is now available in clinical practice, and has become the new clinical gold standard. This test substantially reduces the need for oral peanut challenges (which are time-consuming, expensive and may put patients at risk of severe reaction), and unnecessary prescriptions of adrenaline auto-injectors.</gtr:description><gtr:id>2AFEBCA0-DCE7-4E60-A4C5-F1D3603B7EFD</gtr:id><gtr:impact>My studies in peanut allergy have had substantial impact on clinical practice, and the Academy of Medical Sciences has used this research as an exemplar of internationally competitive medical science with the translation of the acquired knowledge and technology from bench to the delivery of healthcare. I have shown that IgE response to peanut allergen Ara-h-2 is much more predictive of clinical peanut allergy than currently used diagnostic tests to whole peanut extract. The test has been has been made available in the NHS by Phadia AB, marking the beginning of the component-resolved diagnostics (CRD) era in allergy diagnosis. The commercialization of CRD has facilitated the development of products in which IgE to &amp;gt;100 allergen components can be measured simultaneously in small volumes of serum.</gtr:impact><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Ara h 2</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:ukcrnIsctnId>n/a</gtr:ukcrnIsctnId><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Clinical implications: Development of different clinical phenotypes of allergic diseases (asthma, eczema, and rhinitis), as well as asthma severity throughout childhood, is predicted by
the molecular nature of IgE responses to individual allergen components.</gtr:description><gtr:id>81A02D0C-560C-4264-AD3A-285D0D5D64AE</gtr:id><gtr:impact>Our findings suggest that different longitudinal patterns in the development of IgE responses to grass and mite allergen components during childhood are associated with different clinical outcomes and confirm the hypothesis that atopic sensitization can be stratified into subtypes with a diversification of their evolutionary pathways over time. Better resolution of such longitudinal patterns might help us better understand the pathophysiology underlying atopic diseases and might facilitate the development of biomarkers of allergic disease, which can be used for the prediction of future risk.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>ImmunoCAP ISAC (Thermo Fisher Scientific, Uppsala, Sweden)</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Provides a secure online environment to host and share data and outputs from the five STELAR cohorts 
Catalogues and describes the data from each cohort 
Facilitates discovery of available data and formulation of research questions
Provenance of data is clearly available to the users
Facilitates integration of data 
Allows rapid identification of equivalent variables across cohorts for pooled data analysis and meta-analyses 
Provides metadata to assess whether similar variables can be merged 
Social networking tools for academic collaboration
Performing analyses: The code behind each analysis documented and linked to the data and metadata for each study variable involved 
&amp;quot;Research Objects&amp;quot; shared via the e-Lab - results can be reproduced</gtr:description><gtr:id>2EFEF597-28BD-4649-BDAB-547BB8C2D5D3</gtr:id><gtr:impact>Asthma Elab:
1. Provides a secure online environment to host and share data from the five STELAR cohorts. 
2. Catalogues and describe the data from each of the cohorts to facilitate discovery of available data and formulation of research questions.
3. Facilitates integration of data from the different cohorts i.e. provide sufficient metadata to assess whether similar variables are mergable and allow rapid identification of equivalent variables across cohorts for pooled data analysis and meta-analyses.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>STELAR eLAB</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.asthmaelab.org</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The STELAR e-Lab will provide users with a familiar Web 2.0 interface that will allow them to perform many of the actions expected from a document management and social networking web application. The e-Lab is unique in its ability to allow users to create data sets from documents that are imported into the e-Lab. These data sets can be naturally integrated in a manner that allows research questions to be asked across multiple data sets, created by different communities. The data sets are created using data descriptions that are provided by the owners of the data sets. These descriptions provide the e-Lab with comprehensive information about the data in documents. The e-Lab is unlike many other data management systems in that it is designed to operate on any data. Data are stored in a domain independent way such that the software can be easily extended and applied in different contexts.
Architecture
The software team have developed an architecture that will support the generic nature of the e-Lab system while allowing simple interfaces to be developed for the users. This has involved researching state-of-the-art approaches applied by Semantic Web communities for the representation and storage of data. The Resource Description Framework (RDF) will be used to represent datasets; these datasets will be stored and queried using the Bigdata RDF Store.
The software team have considered the longevity and extensibility requirements of the e-Lab software. The e-Lab will implement a plug-in architecture that will allow new software components to be created and simply 'pugged' into the existing system.
The system architecture design is complete. The core system is currently being implemented as extensions to the Alfresco Community Edition 4.2.c content management system.
Data Descriptions
The software team have considered the information required by the e-Lab to create data sets from documents and to allow this data to be integrated with other data sets. This has been influenced by other meta-data standards such as ISO 11179 and those used to model data concepts, such as the Web Ontology Language. The team has developed a language that can be used to express this information and written documentation to support the creation of data descriptions by data managers.
Software has been designed and is currently being implemented that is able to parse the descriptions, created by the data managers, alongside the data documents. This software creates RDF/ XML documents that can be imported into the triple store.
Catalogue
The integration of data from different studies depends on the use of a common vocabulary to describe the data. The software team have worked with MAAS data managers to develop a catalogue of terms. These terms are associated with data using the descriptions to provide the data semantics and context. The software team have developed an XML format for this catalogue that can be used by the e-Lab software and transformed into a human browsable format (e.g. PDF or Word).</gtr:description><gtr:id>90509B4F-5AFD-4743-B952-ACC6FFE2DB47</gtr:id><gtr:impact>The eLab is a multi-purpose platform technology which provides a secure way for researchers to collaborate in the analysis of confidential healthcare data, allowing end-users to share and discuss their analysis methods and findings.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>STELAR Asthma eLab</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>https://asthmaelab.org/share/page</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Brings data, methods and investigators together on-line 
STELAR network on-line: secure web-based environment where investigators collaborate and capture the research in a reproducible way
Mapping the study variables across the cohorts:
Variables mapped across the studies consistently (data manager from each cohort)
Generate rich descriptions (metadata) about each variable to improve the reliability
Managing data securely: Data stored on Asthma e-lab, opening up the analysis process to a range of investigators across the project 
Finding, sharing and reusing subsets of data and scripts for data extraction, derivation, cleaning and analysis 
Performing analyses: The code behind each analysis documented and linked to the data and metadata for each study variable involved. &amp;quot;Research Objects&amp;quot; shared via the e-Lab - results could be reproduced by other member of the consortium 
Networking around results: Investigators comment on results in near real-time via the e-Lab, facilitating timely discussion over the modelling</gtr:description><gtr:id>326C8ECB-3C39-4D75-A42D-429F5D79E401</gtr:id><gtr:impact>Provides a secure online environment to host and share data from the five STELAR cohorts 
Catalogues and describes the data from each of the cohorts 
Facilitates discovery of available data and formulation of research questions
Facilitates integration of data 
Provides sufficient metadata to assess whether similar variables are mergable 
Allows rapid identification of equivalent variables across cohorts for pooled data analysis and meta-analyses 
Social networking tools for academic collaboration 
Provides a space to host and share the outputs</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>eLab</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>https://www.elabdev.org/share/page</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>The Asthma Elab website www.asthmaelab.org has been up and running for over 12 months. This has been built using the open source document management system Alfresco which provides core social networking capabilities for online collaboration including:
User profiles. 
Document sharing &amp;amp; versioning e.g. access to a document can be locked while a user downloads this for editing. 
Online discussion. 
Status updates. 
Ability to comment on documents (including data e.g. comment on a variable).</gtr:description><gtr:id>C34C1CEE-88EB-491F-B4A1-A98D5601F0D2</gtr:id><gtr:impact>1. Provides a secure online environment to host and share data from the five STELAR cohorts. 
2. Catalogues and describe the data from each of the cohorts to facilitate discovery of available data and formulation of research questions.
3. Facilitates integration of data from the different cohorts i.e. provide sufficient metadata to assess whether similar variables are mergable and allow rapid identification of equivalent variables across cohorts for pooled data analysis and meta-analyses. 
4. Provides social networking tools to facilitate academic collaboration. 
5. Provides a space to host and share the output of statistical analysis.</gtr:impact><gtr:title>eLab</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://www.asthmaelab.org</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EE665D5E-7B14-4E10-A611-D13926F6F941"><gtr:id>EE665D5E-7B14-4E10-A611-D13926F6F941</gtr:id><gtr:title>The Study Team for Early Life Asthma Research (STELAR) consortium 'Asthma e-lab': team science bringing data, methods and investigators together.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6d39f523e43fc032d08526f1c4d4c7c"><gtr:id>c6d39f523e43fc032d08526f1c4d4c7c</gtr:id><gtr:otherNames>Custovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/38969A2A-1E5E-44CA-B006-AF12B33015C1"><gtr:id>38969A2A-1E5E-44CA-B006-AF12B33015C1</gtr:id><gtr:title>Effects of long-term exposure to PM10 and NO2 on asthma and wheeze in a prospective birth cohort.</gtr:title><gtr:parentPublicationTitle>Journal of epidemiology and community health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d517dcbc1043a15b9ed45a9a819644ff"><gtr:id>d517dcbc1043a15b9ed45a9a819644ff</gtr:id><gtr:otherNames>M?lter A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-005X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BBB0A83-10CB-4A20-99B6-5E6A039F0253"><gtr:id>6BBB0A83-10CB-4A20-99B6-5E6A039F0253</gtr:id><gtr:title>Evolution pathways of IgE responses to grass and mite allergens throughout childhood.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6d39f523e43fc032d08526f1c4d4c7c"><gtr:id>c6d39f523e43fc032d08526f1c4d4c7c</gtr:id><gtr:otherNames>Custovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3E8C20D-96F6-47EC-9556-37F826A87745"><gtr:id>E3E8C20D-96F6-47EC-9556-37F826A87745</gtr:id><gtr:title>Fraction of exhaled nitric oxide values in childhood are associated with 17q11.2-q12 and 17q12-q21 variants.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ecb46253674f636e2c96beb9b0c03cd5"><gtr:id>ecb46253674f636e2c96beb9b0c03cd5</gtr:id><gtr:otherNames>van der Valk RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D29B1844-6823-482C-83F4-9DF6C86E50E1"><gtr:id>D29B1844-6823-482C-83F4-9DF6C86E50E1</gtr:id><gtr:title>Age, sex and the association between skin test responses and IgE titres with asthma.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c88c70f9e563d1f68f40c55b4e91073c"><gtr:id>c88c70f9e563d1f68f40c55b4e91073c</gtr:id><gtr:otherNames>Mohammad HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E43C1BB5-0444-4199-B18E-9A9CACA43DAC"><gtr:id>E43C1BB5-0444-4199-B18E-9A9CACA43DAC</gtr:id><gtr:title>Pediatric asthma and development of atopy.</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6d39f523e43fc032d08526f1c4d4c7c"><gtr:id>c6d39f523e43fc032d08526f1c4d4c7c</gtr:id><gtr:otherNames>Custovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4C7D180-6A41-4BD4-8A48-31F4979C1976"><gtr:id>C4C7D180-6A41-4BD4-8A48-31F4979C1976</gtr:id><gtr:title>Methylation of IL-2 promoter at birth alters the risk of asthma exacerbations during childhood.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c3dc0e6095797b864f7a496f8537843"><gtr:id>8c3dc0e6095797b864f7a496f8537843</gtr:id><gtr:otherNames>Curtin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7ED2FC02-7E2B-4EB9-826C-1C74DE31F549"><gtr:id>7ED2FC02-7E2B-4EB9-826C-1C74DE31F549</gtr:id><gtr:title>Interaction between glutathione S-transferase variants, maternal smoking and childhood wheezing changes with age.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3eae989d7fe2595c2c6dea57f94ec9e5"><gtr:id>3eae989d7fe2595c2c6dea57f94ec9e5</gtr:id><gtr:otherNames>Wu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA0018CA-EEC6-4699-86CF-78DAEE199526"><gtr:id>EA0018CA-EEC6-4699-86CF-78DAEE199526</gtr:id><gtr:title>Cross-sectional association of dietary patterns with asthma and atopic sensitization in childhood - in a cohort study.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2e25a4fa01d4e26232388505f7d2e49"><gtr:id>c2e25a4fa01d4e26232388505f7d2e49</gtr:id><gtr:otherNames>Patel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF0A3E20-A756-4CE5-86DB-39E8583A549A"><gtr:id>FF0A3E20-A756-4CE5-86DB-39E8583A549A</gtr:id><gtr:title>Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5805bef685b0f49e1fecb282e26086"><gtr:id>db5805bef685b0f49e1fecb282e26086</gtr:id><gtr:otherNames>Felix JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A9AEBF1-625C-47CA-AA54-9B9B0E43CBDC"><gtr:id>2A9AEBF1-625C-47CA-AA54-9B9B0E43CBDC</gtr:id><gtr:title>A multicentre study of air pollution exposure and childhood asthma prevalence: the ESCAPE project.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d517dcbc1043a15b9ed45a9a819644ff"><gtr:id>d517dcbc1043a15b9ed45a9a819644ff</gtr:id><gtr:otherNames>M?lter A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84351D87-5F75-4C0D-BB85-308548D3EF1B"><gtr:id>84351D87-5F75-4C0D-BB85-308548D3EF1B</gtr:id><gtr:title>The importance of being earnest in epidemiology.</gtr:title><gtr:parentPublicationTitle>Acta paediatrica (Oslo, Norway : 1992)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2d5e91fa7f5ab8da69b747c6d2f971e"><gtr:id>b2d5e91fa7f5ab8da69b747c6d2f971e</gtr:id><gtr:otherNames>Belgrave D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0803-5253</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C421C7C4-8514-4C41-96BC-398C8B9559A2"><gtr:id>C421C7C4-8514-4C41-96BC-398C8B9559A2</gtr:id><gtr:title>Evolution pathways of IgE responses to grass and mite allergens throughout childhood.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6d39f523e43fc032d08526f1c4d4c7c"><gtr:id>c6d39f523e43fc032d08526f1c4d4c7c</gtr:id><gtr:otherNames>Custovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B283710D-E0E2-4355-819C-934F61B179FB"><gtr:id>B283710D-E0E2-4355-819C-934F61B179FB</gtr:id><gtr:title>Disaggregating asthma: Big investigation versus big data.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2d5e91fa7f5ab8da69b747c6d2f971e"><gtr:id>b2d5e91fa7f5ab8da69b747c6d2f971e</gtr:id><gtr:otherNames>Belgrave D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/976A2D86-4F0A-4A6C-8CBD-1C7989D9FCFF"><gtr:id>976A2D86-4F0A-4A6C-8CBD-1C7989D9FCFF</gtr:id><gtr:title>Differing associations of BMI and body fat with asthma and lung function in children.</gtr:title><gtr:parentPublicationTitle>Pediatric pulmonology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17f6633e9d8a0b4804343fbc2df4165c"><gtr:id>17f6633e9d8a0b4804343fbc2df4165c</gtr:id><gtr:otherNames>Wang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1099-0496</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11A6EA95-30F6-4746-8746-6682B17C2F5D"><gtr:id>11A6EA95-30F6-4746-8746-6682B17C2F5D</gtr:id><gtr:title>Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcd5ab5f8969fd549cae900cd28e2fa7"><gtr:id>fcd5ab5f8969fd549cae900cd28e2fa7</gtr:id><gtr:otherNames>Belgrave DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/35B1828B-8033-4018-A766-30135D5CB102"><gtr:id>35B1828B-8033-4018-A766-30135D5CB102</gtr:id><gtr:title>Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e0139d19d0f91588edb2f39241fbfe1"><gtr:id>3e0139d19d0f91588edb2f39241fbfe1</gtr:id><gtr:otherNames>B?nnelykke K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A6B34BCA-2F2C-425F-AE9F-60C76C5E9215"><gtr:id>A6B34BCA-2F2C-425F-AE9F-60C76C5E9215</gtr:id><gtr:title>Long-term exposure to PM10 and NO2 in association with lung volume and airway resistance in the MAAS birth cohort.</gtr:title><gtr:parentPublicationTitle>Environmental health perspectives</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d517dcbc1043a15b9ed45a9a819644ff"><gtr:id>d517dcbc1043a15b9ed45a9a819644ff</gtr:id><gtr:otherNames>M?lter A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF1617DC-D1CA-450D-8D63-7BFD8688B446"><gtr:id>FF1617DC-D1CA-450D-8D63-7BFD8688B446</gtr:id><gtr:title>Relationship between cytokine expression patterns and clinical outcomes: two population-based birth cohorts.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3eae989d7fe2595c2c6dea57f94ec9e5"><gtr:id>3eae989d7fe2595c2c6dea57f94ec9e5</gtr:id><gtr:otherNames>Wu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CC14DFE3-C3F8-4962-AA34-6F4FD73B7520"><gtr:id>CC14DFE3-C3F8-4962-AA34-6F4FD73B7520</gtr:id><gtr:title>Challenges in interpreting wheeze phenotypes: the clinical implications of statistical learning techniques.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2d5e91fa7f5ab8da69b747c6d2f971e"><gtr:id>b2d5e91fa7f5ab8da69b747c6d2f971e</gtr:id><gtr:otherNames>Belgrave D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1C5A215-A8FA-45CC-B14D-EC1018EF259B"><gtr:id>E1C5A215-A8FA-45CC-B14D-EC1018EF259B</gtr:id><gtr:title>Characterizing wheeze phenotypes to identify endotypes of childhood asthma, and the implications for future management.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcd5ab5f8969fd549cae900cd28e2fa7"><gtr:id>fcd5ab5f8969fd549cae900cd28e2fa7</gtr:id><gtr:otherNames>Belgrave DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A884E92-728F-4F31-B262-D8FF98199422"><gtr:id>3A884E92-728F-4F31-B262-D8FF98199422</gtr:id><gtr:title>Atopic Dermatitis and Respiratory Allergy: What is the Link.</gtr:title><gtr:parentPublicationTitle>Current dermatology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcd5ab5f8969fd549cae900cd28e2fa7"><gtr:id>fcd5ab5f8969fd549cae900cd28e2fa7</gtr:id><gtr:otherNames>Belgrave DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2162-4933</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0548B90B-48F3-4678-8171-A886AC3E2314"><gtr:id>0548B90B-48F3-4678-8171-A886AC3E2314</gtr:id><gtr:title>Epigenome-wide analysis links SMAD3 methylation at birth to asthma in children of asthmatic mothers.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e8a98f8dd545b8c1c2616ee3f146dae4"><gtr:id>e8a98f8dd545b8c1c2616ee3f146dae4</gtr:id><gtr:otherNames>DeVries A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AACC46DD-49C0-4CFA-BD1F-F0F1E610AFCB"><gtr:id>AACC46DD-49C0-4CFA-BD1F-F0F1E610AFCB</gtr:id><gtr:title>A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e0139d19d0f91588edb2f39241fbfe1"><gtr:id>3e0139d19d0f91588edb2f39241fbfe1</gtr:id><gtr:otherNames>B?nnelykke K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5787DBE6-35FF-4A30-810D-4819585FB45C"><gtr:id>5787DBE6-35FF-4A30-810D-4819585FB45C</gtr:id><gtr:title>Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25dcd7f9bafbbcd6f229ae06da737fee"><gtr:id>25dcd7f9bafbbcd6f229ae06da737fee</gtr:id><gtr:otherNames>Prosperi MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD172800-2854-40AC-ADCA-EB3D039AADA1"><gtr:id>AD172800-2854-40AC-ADCA-EB3D039AADA1</gtr:id><gtr:title>Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3cf3af01f885c72dd9a7367253b8cc4e"><gtr:id>3cf3af01f885c72dd9a7367253b8cc4e</gtr:id><gtr:otherNames>Lazic N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB276820-4554-45A8-8AE3-276E6B7D5D0E"><gtr:id>FB276820-4554-45A8-8AE3-276E6B7D5D0E</gtr:id><gtr:title>Predicting phenotypes of asthma and eczema with machine learning.</gtr:title><gtr:parentPublicationTitle>BMC medical genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25dcd7f9bafbbcd6f229ae06da737fee"><gtr:id>25dcd7f9bafbbcd6f229ae06da737fee</gtr:id><gtr:otherNames>Prosperi MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1755-8794</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E9C8D8E-877D-42CE-8399-86EC9EDADF9B"><gtr:id>2E9C8D8E-877D-42CE-8399-86EC9EDADF9B</gtr:id><gtr:title>Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a4f934204f77f76ae293d3fd9520cee5"><gtr:id>a4f934204f77f76ae293d3fd9520cee5</gtr:id><gtr:otherNames>Semic-Jusufagic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6C35B0C4-631E-4F80-9E96-BB29FD9BA54F"><gtr:id>6C35B0C4-631E-4F80-9E96-BB29FD9BA54F</gtr:id><gtr:title>Distinguishing Asthma Phenotypes Using Machine Learning Approaches.</gtr:title><gtr:parentPublicationTitle>Current allergy and asthma reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3067e778d78729b9fae425777dd1368a"><gtr:id>3067e778d78729b9fae425777dd1368a</gtr:id><gtr:otherNames>Howard R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D47F92D8-005B-4223-9062-13F693D24898"><gtr:id>D47F92D8-005B-4223-9062-13F693D24898</gtr:id><gtr:title>Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f880521b89d60d1249d372fa4d06e6b"><gtr:id>0f880521b89d60d1249d372fa4d06e6b</gtr:id><gtr:otherNames>Guerra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2C0DECB-ECF8-4E60-8D09-5A9F01B3D1FE"><gtr:id>A2C0DECB-ECF8-4E60-8D09-5A9F01B3D1FE</gtr:id><gtr:title>Distinguishing benign from pathologic TH2 immunity in atopic children.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c8c54eb69be2f4909c18b38f12c00a66"><gtr:id>c8c54eb69be2f4909c18b38f12c00a66</gtr:id><gtr:otherNames>Holt PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD932592-9822-4F77-A910-315B5FBE216F"><gtr:id>FD932592-9822-4F77-A910-315B5FBE216F</gtr:id><gtr:title>Air pollution exposure and lung function in children: the ESCAPE project.</gtr:title><gtr:parentPublicationTitle>Environmental health perspectives</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03c21f57fcde70364d64c603117c4fb6"><gtr:id>03c21f57fcde70364d64c603117c4fb6</gtr:id><gtr:otherNames>Gehring U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D1CCCFC-B2E6-45F3-A9FE-2A299C81947D"><gtr:id>3D1CCCFC-B2E6-45F3-A9FE-2A299C81947D</gtr:id><gtr:title>Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3fff870985131b893b7254f573f4031a"><gtr:id>3fff870985131b893b7254f573f4031a</gtr:id><gtr:otherNames>Simpson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50A4218F-70AE-4785-9BA8-E0F0379EB244"><gtr:id>50A4218F-70AE-4785-9BA8-E0F0379EB244</gtr:id><gtr:title>Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25dcd7f9bafbbcd6f229ae06da737fee"><gtr:id>25dcd7f9bafbbcd6f229ae06da737fee</gtr:id><gtr:otherNames>Prosperi MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52A35014-F541-441C-B4A3-766DCEC7188C"><gtr:id>52A35014-F541-441C-B4A3-766DCEC7188C</gtr:id><gtr:title>Trajectories of lung function during childhood.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcd5ab5f8969fd549cae900cd28e2fa7"><gtr:id>fcd5ab5f8969fd549cae900cd28e2fa7</gtr:id><gtr:otherNames>Belgrave DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0958A998-A931-4FA4-A99C-9B9FF78F0D2B"><gtr:id>0958A998-A931-4FA4-A99C-9B9FF78F0D2B</gtr:id><gtr:title>Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea922bc4db1d3ac9a99cc64f7d1d0eea"><gtr:id>ea922bc4db1d3ac9a99cc64f7d1d0eea</gtr:id><gtr:otherNames>Paternoster L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA93E894-729C-45DB-ACE9-D531BE1E35B7"><gtr:id>AA93E894-729C-45DB-ACE9-D531BE1E35B7</gtr:id><gtr:title>Asthma phenotypes in childhood.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b09b98c60b03af49292f2edbd64a356"><gtr:id>1b09b98c60b03af49292f2edbd64a356</gtr:id><gtr:otherNames>Deliu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A8AEB6D-755F-438C-80C2-B0FD7783778E"><gtr:id>2A8AEB6D-755F-438C-80C2-B0FD7783778E</gtr:id><gtr:title>Genetic variants in endotoxin signalling pathway, domestic endotoxin exposure and asthma exacerbations.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6419cba081cc68258cb05991c212957e"><gtr:id>6419cba081cc68258cb05991c212957e</gtr:id><gtr:otherNames>Kljaic-Bukvic B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A32ABFF1-AA23-47D8-A195-0C0AA5B5AB03"><gtr:id>A32ABFF1-AA23-47D8-A195-0C0AA5B5AB03</gtr:id><gtr:title>Elemental composition of particulate matter and the association with lung function.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ec3036f513613d3ecdae5e28013d0123"><gtr:id>ec3036f513613d3ecdae5e28013d0123</gtr:id><gtr:otherNames>Eeftens M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50A5646D-30B1-4F8D-BE86-45E179DE15DC"><gtr:id>50A5646D-30B1-4F8D-BE86-45E179DE15DC</gtr:id><gtr:title>Challenges in identifying asthma subgroups using unsupervised statistical learning techniques.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25dcd7f9bafbbcd6f229ae06da737fee"><gtr:id>25dcd7f9bafbbcd6f229ae06da737fee</gtr:id><gtr:otherNames>Prosperi MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F1B6FE7-6D13-4A6A-AA29-C4AC20278218"><gtr:id>9F1B6FE7-6D13-4A6A-AA29-C4AC20278218</gtr:id><gtr:title>Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6d7479da87c295dbb6a12108c74ccf59"><gtr:id>6d7479da87c295dbb6a12108c74ccf59</gtr:id><gtr:otherNames>Brough HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20ED7C57-FA85-46DE-AAE5-FC9F19F2BFC0"><gtr:id>20ED7C57-FA85-46DE-AAE5-FC9F19F2BFC0</gtr:id><gtr:title>Identification of Asthma Subtypes Using Clustering Methodologies.</gtr:title><gtr:parentPublicationTitle>Pulmonary therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b09b98c60b03af49292f2edbd64a356"><gtr:id>1b09b98c60b03af49292f2edbd64a356</gtr:id><gtr:otherNames>Deliu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2364-1754</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A7A6E3D4-5C7F-43D6-B50F-FE5855CC2ED8"><gtr:id>A7A6E3D4-5C7F-43D6-B50F-FE5855CC2ED8</gtr:id><gtr:title>Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcd5ab5f8969fd549cae900cd28e2fa7"><gtr:id>fcd5ab5f8969fd549cae900cd28e2fa7</gtr:id><gtr:otherNames>Belgrave DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80E236EA-FFBB-463E-AAD0-FB8EF6386A34"><gtr:id>80E236EA-FFBB-463E-AAD0-FB8EF6386A34</gtr:id><gtr:title>Polymorphisms of endotoxin pathway and endotoxin exposure: in vitro IgE synthesis and replication in a birth cohort.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/385842490e4708018b120568654a136f"><gtr:id>385842490e4708018b120568654a136f</gtr:id><gtr:otherNames>Sahiner UM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3F9E867-FD8E-47EF-86FA-DE8C5EE5B61F"><gtr:id>F3F9E867-FD8E-47EF-86FA-DE8C5EE5B61F</gtr:id><gtr:title>Impact of rhinitis on asthma severity in school-age children.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b09b98c60b03af49292f2edbd64a356"><gtr:id>1b09b98c60b03af49292f2edbd64a356</gtr:id><gtr:otherNames>Deliu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A74A4FC-0473-42AC-A4B1-17B223714A03"><gtr:id>4A74A4FC-0473-42AC-A4B1-17B223714A03</gtr:id><gtr:title>A novel common variant in DCST2 is associated with length in early life and height in adulthood.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ecb46253674f636e2c96beb9b0c03cd5"><gtr:id>ecb46253674f636e2c96beb9b0c03cd5</gtr:id><gtr:otherNames>van der Valk RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/445DE393-36BE-41E2-BB3D-0F33FB28D501"><gtr:id>445DE393-36BE-41E2-BB3D-0F33FB28D501</gtr:id><gtr:title>Shared genetic variants suggest common pathways in allergy and autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95877b7523985e0413e056c78843520c"><gtr:id>95877b7523985e0413e056c78843520c</gtr:id><gtr:otherNames>Kreiner E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K002449/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>